Skip to content
Search

Latest Stories

Latest stats show a 20% rise in MS patient numbers

There is a 20 per cent increase in the estimated number of people in the UK living with multiple sclerosis (MS), according to latest figures.

The new data from Public Health England (PHE) and the MS Society, published today, shows that over 130,000 people in the country are now living with MS, compared to the 2018 estimate of 110,000.


The number of people with the condition in all four UK nations has increased, with Scotland seeing the biggest rise from 11,300 to 15,700.

The estimated number of new cases of MS identified each year also increased from 5,000 a year in 2018 to 6,700.

The figures reveal that one in every 500 people in the UK is living with MS, while about 130 people are diagnosed every week on average.

MS Society views the latest figures as confirmation of many more people living with the condition in the UK than previous estimates.

Dr Susan Kohlhaas, Director of Research and External Affairs at the MS Society, said: “While the NHS is getting better at diagnosing and recording cases of MS, unfortunately in many important ways society is getting worse at supporting people with the condition. Compared to just a few years ago, fewer people with MS receive social care support and key welfare payments – and we hear far too many stories of people struggling to stay in work without the adjustments they need.”

“MS is relentless, painful and disabling and people with the condition desperately need the Government to step up and create an expanded and sustainable social care system, overhaul the way benefits are assessed and strengthen rights for employee support,” Dr Kohlhaas added.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less